Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)Hiroko Minatogawa, Takako Eguchi Nakajima, Naoki Izawa et al.|British Journal of Cancer|2023Cited by 18
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line TreatmentTakuro Mizukami, Takako Eguchi Nakajima, Koki Hamaji et al.|Nutrition and Cancer|2021Cited by 12
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)Ryohei Kawabata, Masashi Fujii, Masato Nakamura et al.|Targeted Oncology|2023Cited by 5